Report Detail

Request for Sample of this report

Service & Software Global NGS Tumor Gene Analysis Software Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4542541
    • |
  • 19 July, 2023
    • |
  • Global
    • |
  • 100 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global NGS Tumor Gene Analysis Software market size was valued at USD 1552.7 million in 2022 and is forecast to a readjusted size of USD 4590 million by 2029 with a CAGR of 16.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.
This report is a detailed and comprehensive analysis for global NGS Tumor Gene Analysis Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global NGS Tumor Gene Analysis Software market size and forecasts, in consumption value ($ Million), 2018-2029
Global NGS Tumor Gene Analysis Software market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global NGS Tumor Gene Analysis Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global NGS Tumor Gene Analysis Software market shares of main players, in revenue ($ Million), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for NGS Tumor Gene Analysis Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global NGS Tumor Gene Analysis Software market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Illumina, Thermo Fisher Scientific, BGI Group and Novogene, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
NGS Tumor Gene Analysis Software market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Non-Small Cell Lung Cancer
Human 6 Gene Mutations
Human 12 Gene Mutations
Other
Market segment by Application
Hospitals and Health Systems
Research Institute
Other
Market segment by players, this report covers
Roche
Illumina
Thermo Fisher Scientific
BGI Group
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
GTH.O
Golden Helix, Inc
Diatech Pharmacogenetics
ViennaLab Diagnostics GmbH
3D Medicines
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe NGS Tumor Gene Analysis Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of NGS Tumor Gene Analysis Software, with revenue, gross margin and global market share of NGS Tumor Gene Analysis Software from 2018 to 2023.
Chapter 3, the NGS Tumor Gene Analysis Software competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and NGS Tumor Gene Analysis Software market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of NGS Tumor Gene Analysis Software.
Chapter 13, to describe NGS Tumor Gene Analysis Software research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of NGS Tumor Gene Analysis Software
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of NGS Tumor Gene Analysis Software by Type
    • 1.3.1 Overview: Global NGS Tumor Gene Analysis Software Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Type in 2022
    • 1.3.3 Non-Small Cell Lung Cancer
    • 1.3.4 Human 6 Gene Mutations
    • 1.3.5 Human 12 Gene Mutations
    • 1.3.6 Other
  • 1.4 Global NGS Tumor Gene Analysis Software Market by Application
    • 1.4.1 Overview: Global NGS Tumor Gene Analysis Software Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals and Health Systems
    • 1.4.3 Research Institute
    • 1.4.4 Other
  • 1.5 Global NGS Tumor Gene Analysis Software Market Size & Forecast
  • 1.6 Global NGS Tumor Gene Analysis Software Market Size and Forecast by Region
    • 1.6.1 Global NGS Tumor Gene Analysis Software Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global NGS Tumor Gene Analysis Software Market Size by Region, (2018-2029)
    • 1.6.3 North America NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
    • 1.6.4 Europe NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
    • 1.6.6 South America NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa NGS Tumor Gene Analysis Software Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche NGS Tumor Gene Analysis Software Product and Solutions
    • 2.1.4 Roche NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Illumina
    • 2.2.1 Illumina Details
    • 2.2.2 Illumina Major Business
    • 2.2.3 Illumina NGS Tumor Gene Analysis Software Product and Solutions
    • 2.2.4 Illumina NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Illumina Recent Developments and Future Plans
  • 2.3 Thermo Fisher Scientific
    • 2.3.1 Thermo Fisher Scientific Details
    • 2.3.2 Thermo Fisher Scientific Major Business
    • 2.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product and Solutions
    • 2.3.4 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.4 BGI Group
    • 2.4.1 BGI Group Details
    • 2.4.2 BGI Group Major Business
    • 2.4.3 BGI Group NGS Tumor Gene Analysis Software Product and Solutions
    • 2.4.4 BGI Group NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 BGI Group Recent Developments and Future Plans
  • 2.5 Novogene
    • 2.5.1 Novogene Details
    • 2.5.2 Novogene Major Business
    • 2.5.3 Novogene NGS Tumor Gene Analysis Software Product and Solutions
    • 2.5.4 Novogene NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Novogene Recent Developments and Future Plans
  • 2.6 Geneseeq
    • 2.6.1 Geneseeq Details
    • 2.6.2 Geneseeq Major Business
    • 2.6.3 Geneseeq NGS Tumor Gene Analysis Software Product and Solutions
    • 2.6.4 Geneseeq NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Geneseeq Recent Developments and Future Plans
  • 2.7 AmoyDx
    • 2.7.1 AmoyDx Details
    • 2.7.2 AmoyDx Major Business
    • 2.7.3 AmoyDx NGS Tumor Gene Analysis Software Product and Solutions
    • 2.7.4 AmoyDx NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 AmoyDx Recent Developments and Future Plans
  • 2.8 Burning Rock Medicine
    • 2.8.1 Burning Rock Medicine Details
    • 2.8.2 Burning Rock Medicine Major Business
    • 2.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Product and Solutions
    • 2.8.4 Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Burning Rock Medicine Recent Developments and Future Plans
  • 2.9 GTH.O
    • 2.9.1 GTH.O Details
    • 2.9.2 GTH.O Major Business
    • 2.9.3 GTH.O NGS Tumor Gene Analysis Software Product and Solutions
    • 2.9.4 GTH.O NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 GTH.O Recent Developments and Future Plans
  • 2.10 Golden Helix, Inc
    • 2.10.1 Golden Helix, Inc Details
    • 2.10.2 Golden Helix, Inc Major Business
    • 2.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Product and Solutions
    • 2.10.4 Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Golden Helix, Inc Recent Developments and Future Plans
  • 2.11 Diatech Pharmacogenetics
    • 2.11.1 Diatech Pharmacogenetics Details
    • 2.11.2 Diatech Pharmacogenetics Major Business
    • 2.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product and Solutions
    • 2.11.4 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Diatech Pharmacogenetics Recent Developments and Future Plans
  • 2.12 ViennaLab Diagnostics GmbH
    • 2.12.1 ViennaLab Diagnostics GmbH Details
    • 2.12.2 ViennaLab Diagnostics GmbH Major Business
    • 2.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product and Solutions
    • 2.12.4 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 ViennaLab Diagnostics GmbH Recent Developments and Future Plans
  • 2.13 3D Medicines
    • 2.13.1 3D Medicines Details
    • 2.13.2 3D Medicines Major Business
    • 2.13.3 3D Medicines NGS Tumor Gene Analysis Software Product and Solutions
    • 2.13.4 3D Medicines NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 3D Medicines Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global NGS Tumor Gene Analysis Software Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of NGS Tumor Gene Analysis Software by Company Revenue
    • 3.2.2 Top 3 NGS Tumor Gene Analysis Software Players Market Share in 2022
    • 3.2.3 Top 6 NGS Tumor Gene Analysis Software Players Market Share in 2022
  • 3.3 NGS Tumor Gene Analysis Software Market: Overall Company Footprint Analysis
    • 3.3.1 NGS Tumor Gene Analysis Software Market: Region Footprint
    • 3.3.2 NGS Tumor Gene Analysis Software Market: Company Product Type Footprint
    • 3.3.3 NGS Tumor Gene Analysis Software Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global NGS Tumor Gene Analysis Software Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global NGS Tumor Gene Analysis Software Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global NGS Tumor Gene Analysis Software Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global NGS Tumor Gene Analysis Software Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
  • 6.2 North America NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
  • 6.3 North America NGS Tumor Gene Analysis Software Market Size by Country
    • 6.3.1 North America NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
    • 6.3.2 United States NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 6.3.3 Canada NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
  • 7.2 Europe NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
  • 7.3 Europe NGS Tumor Gene Analysis Software Market Size by Country
    • 7.3.1 Europe NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
    • 7.3.2 Germany NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 7.3.3 France NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 7.3.5 Russia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 7.3.6 Italy NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region
    • 8.3.1 Asia-Pacific NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2029)
    • 8.3.2 China NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 8.3.3 Japan NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 8.3.5 India NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 8.3.7 Australia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
  • 9.2 South America NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
  • 9.3 South America NGS Tumor Gene Analysis Software Market Size by Country
    • 9.3.1 South America NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country
    • 10.3.1 Middle East & Africa NGS Tumor Gene Analysis Software Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)
    • 10.3.4 UAE NGS Tumor Gene Analysis Software Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 NGS Tumor Gene Analysis Software Market Drivers
  • 11.2 NGS Tumor Gene Analysis Software Market Restraints
  • 11.3 NGS Tumor Gene Analysis Software Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 NGS Tumor Gene Analysis Software Industry Chain
  • 12.2 NGS Tumor Gene Analysis Software Upstream Analysis
  • 12.3 NGS Tumor Gene Analysis Software Midstream Analysis
  • 12.4 NGS Tumor Gene Analysis Software Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on NGS Tumor Gene Analysis Software. Industry analysis & Market Report on NGS Tumor Gene Analysis Software is a syndicated market report, published as Global NGS Tumor Gene Analysis Software Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of NGS Tumor Gene Analysis Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,232.92
    		4,849.38
    		6,465.84
    		541,105.20
    		811,657.80
    		1,082,210.40
    		290,510.40
    		435,765.60
    		581,020.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo